Notably, type 2 cytokine responses (IL-5) and neutrophil responses (CXCL8/IL-8) were not altered by the changes of CD40 expression, suggesting that CD40 expression specifically correlates to the T-cell-dependent antitumor immunity in human melanoma tumors. The gene discussed is CD40; the disease is melanoma.